Brazil, where the obesity rate has surged over the past decade, is now the biggest growth driver for weight-loss treatments in the world and the No. 2 market for Saxenda, Novo Nordisk A/S’s industry-leading drug.
from Hindustan Times - world https://ift.tt/2Ok2shY
Subscribe to:
Post Comments (Atom)
-
Permanent residents in Qatar would be allowed to have free state education, healthcare and be given the right to own property. from Hindus...
-
President Donald Trump's decision to cancel his historic meeting with North Korea's Kim Jong Un left South Korea's President ...
No comments:
Post a Comment